← Back
Data updated: Mar 10, 2026
NEW HEIGHTSRX
CardiovascularOphthalmologyInfectious Disease
NEW HEIGHTSRX is a generic drug manufacturer focused on Cardiovascular, Ophthalmology, Infectious Disease.
1995
Since
4
Drugs
-
Trials
37
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CIPROFLOXACIN HYDROCHLORIDE 2025-12-17
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
CIPROFLOXACIN HYDROCHLORIDE 2025-09-30
Labeling
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE 2025-09-03
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 25%
1 drugs
Ophthalmology 25%
1 drugs
Infectious Disease 25%
1 drugs
Dermatology 25%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology, Ophthalmology
B BRAUN specialty
Infectious Disease, Ophthalmology, Dermatology, Cardiovascular
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Infectious Disease, Dermatology
FOUGERA PHARMS other
Dermatology, Ophthalmology, Infectious Disease, Cardiovascular
Bayer big-pharma
Cardiovascular, Ophthalmology, Dermatology
Discontinued (2)
Company Info
- First Approval
- 1995-05-31
- Latest
- 2025-02-18
- Applications
- 4